tradingkey.logo
tradingkey.logo
Search

Shuttle Pharmaceuticals Holdings Inc

SHPH
Add to Watchlist
2.920USD
0.0000.00%
Close 07-27 16:00ETQuotes delayed by 15 min
1.62MMarket Cap
264.25P/E TTM

SHPH Financials

See Shuttle Pharmaceuticals Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Shuttle Pharmaceuticals Holdings Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.43/--
Revenue / Forecast
0.00/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-71.56
10.16%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2017Q3
FY2017Q2
FY2017Q1
Financial Indicators
EPS
43.68%-4.28
93.22%-0.94
97.35%-1.05
86.36%-3.29
63.64%-7.60
32.05%-13.92
-74.23%-39.68
21.25%-24.12
-46.06%-20.89
-86.27%-20.49
---22.77
---30.63
---14.30
---11.00
---34.57
----
----
----
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
Net Profit
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-76.12%-1.79M
-250.60%-2.18M
-37.80%-975.10K
-54.89%-750.91K
-319.36%-1.02M
-67.23%-623.04K
-356.25%-707.61K
---484.81K
---242.73K
---372.57K
----
----
----
Debt to assets ratio
----
----
-68.25%11.78%
-72.42%8.10%
-21.94%15.46%
184.05%34.89%
358.40%37.12%
564.35%29.37%
37.00%19.80%
55.07%12.28%
--8.10%
--4.42%
--14.45%
--7.92%
--7.31%
----
----
----
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
Operating profit
24.89%-2.22M
-56.90%-2.79M
25.71%-2.27M
-163.75%-3.91M
-113.11%-2.95M
-38.53%-1.78M
-90.82%-3.05M
-1.16%-1.48M
10.35%-1.38M
-73.17%-1.28M
-94.67%-1.60M
-314.46%-1.47M
-141.98%-1.54M
25.06%-740.79K
-239.29%-821.47K
-5.17%-353.63K
-262.55%-638.40K
---988.54K
---242.12K
---336.25K
----
----
----
Net Profit
29.50%-2.15M
-63.59%-2.61M
37.97%-2.35M
-82.48%-3.71M
-76.37%-3.05M
2.56%-1.60M
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-118.47%-1.64M
-76.12%-1.79M
-250.60%-2.18M
-37.80%-975.10K
-54.89%-750.91K
-319.36%-1.02M
-67.23%-623.04K
-356.25%-707.61K
---484.81K
---242.73K
---372.57K
----
----
----
Current assets
-50.34%2.46M
-77.25%502.91K
803.81%3.27M
108.90%5.19M
12.43%4.96M
-60.47%2.21M
-94.83%361.35K
-70.56%2.49M
-57.47%4.41M
-34.80%5.59M
-24.69%7.00M
13102.62%8.44M
2332.03%10.37M
--8.58M
--9.29M
--63.95K
--426.47K
----
----
----
-28.18%152.14K
--313.26K
--163.35K
Total current liabilities
366.04%8.31M
419.43%7.97M
18.42%1.96M
22.26%1.69M
19.67%1.78M
47.16%1.53M
104.73%1.66M
180.47%1.38M
7.26%1.49M
6.82%1.04M
-16.49%810.44K
-79.88%493.68K
-41.12%1.39M
--975.68K
--970.47K
--2.45M
--2.36M
----
----
----
209.21%356.43K
--475.54K
--252.32K
Total assets
122.39%11.81M
317.99%10.48M
425.99%3.54M
95.68%5.50M
11.70%5.31M
-57.89%2.51M
-90.87%673.57K
-68.17%2.81M
-54.45%4.75M
-31.22%5.95M
-21.38%7.38M
4994.02%8.84M
1789.14%10.44M
--8.65M
--9.38M
--173.48K
--552.45K
----
----
----
-31.21%176.39K
--342.34K
--197.27K
Total liabilities
317.95%8.46M
357.48%8.22M
8.04%2.15M
-5.60%1.90M
1.63%2.02M
-5.21%1.80M
12.62%1.99M
5.79%2.01M
-43.56%1.99M
94.32%1.90M
80.74%1.77M
-23.31%1.90M
46.96%3.53M
--975.68K
--977.14K
--2.48M
--2.40M
----
----
----
102.39%476.68K
--595.78K
--372.57K
Total equity
1.86%3.35M
217.91%2.25M
205.99%1.39M
349.88%3.61M
18.97%3.29M
-82.51%709.15K
-123.45%-1.32M
-88.44%801.43K
-60.02%2.76M
-47.18%4.06M
-33.26%5.61M
400.75%6.94M
473.41%6.91M
--7.68M
--8.40M
---2.31M
---1.85M
----
----
----
-1537.72%-300.30K
---253.45K
---175.30K
Net operating income
4.34%-2.42M
63.83%-973.01K
-31.42%-2.63M
-139.76%-3.36M
-103.94%-2.53M
-153.27%-2.69M
-30.21%-2.00M
14.99%-1.40M
7.39%-1.24M
-56.23%-1.06M
-46.11%-1.53M
-363.13%-1.65M
-114.21%-1.34M
-403.04%-679.87K
-5888.14%-1.05M
-766.48%-355.42K
-485.81%-624.61K
---135.15K
---17.54K
---41.02K
----
----
----
Net investment
---36.00K
---3.06M
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
6506.87%1.66M
1743.79%1.16M
103.43%101.30K
--87.04K
---25.86K
--62.80K
---2.95M
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
Net financing
-37.31%3.21M
-49.05%2.27M
51.03%-96.38K
892.81%3.66M
12898.47%5.12M
1431.66%4.45M
---196.79K
-231.59%-461.67K
-101.31%-40.00K
-1334.15%-334.44K
-100.00%0.00
---139.23K
478.97%3.04M
-104.71%-23.32K
8333.76%10.12M
--0.00
620.09%525.72K
--494.93K
--120.00K
--0.00
----
----
----

FAQs

What are the current assets of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its current assets were 502.91K, with a year-on-year change of -77.25.

What are the total assets of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its total assets of Shuttle Pharmaceuticals Holdings Inc were 10.48M, with a year-on-year change of 317.99.

What are the total liabilities of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its total liabilities of Shuttle Pharmaceuticals Holdings Inc were 8.22M, with a year-on-year change of 357.48.

What is the total equity of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its total equity of Shuttle Pharmaceuticals Holdings Inc was 2.25M, with a year-on-year change of 217.91.

What is the net operating income of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its net operating income of Shuttle Pharmaceuticals Holdings Inc was -11.92M, with a year-on-year change of -54.84.

What is the net investment of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its net investment of Shuttle Pharmaceuticals Holdings Inc was -3.06M, with a year-on-year change of -204.83.

What is the net financing of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its net financing of Shuttle Pharmaceuticals Holdings Inc was 10.95M, with a year-on-year change of 191.66.

What is the Earnings Per Share (EPS) of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -71.56, with a year-on-year change of 10.16.

What is the net income of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its net income was -11.72M, with a year-on-year change of -28.18.

What is the Return on Equity (ROE) of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -791.04, with a year-on-year change of -106.09.

What is the Return on Assets (ROA) of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -180.58, with a year-on-year change of 16.49.

What is the operating profit of Shuttle Pharmaceuticals Holdings Inc?

According to Shuttle Pharmaceuticals Holdings Inc's FY2025 earnings report, its operating profit was -11.92M, with a year-on-year change of -54.84.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.